Chapter 20 Gavi-Automated Vitrification Instrument

  • Tammie K. RoyEmail author
  • Susanna Brandi
  • Teija T. Peura
Part of the Methods in Molecular Biology book series (MIMB, volume 1568)


Gavi is intended for use in a laboratory or clinic environment for the preparation and vitrification of oocytes, cleavage stage embryos and blastocysts. Gavi is designed to automate the equilibration steps in the vitrification process to minimize the variability that occurs during cryopreservation. This automated process reduces the potential for errors and ensures a standardized, repeatable procedure for vitrification in a controlled, closed-system environment.

Key words

Automation Cryopreservation Embryo Gavi IVF Standardization Vitrification 

Supplementary material

Gavi vitrification (MP4 684289 kb)

Gavi warming (MP4 379301 kb)


  1. 1.
    Kuwayama M (2007) Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology 67:73–80CrossRefPubMedGoogle Scholar
  2. 2.
    Roy TK, Bradley CK, Bowman MC et al (2014) Single-embryo transfer of vitrified-warmed blastocysts yields equivalent live-birth rates and improved neonatal outcomes compared with fresh transfers. Fertil Steril 101:1294–1301CrossRefPubMedGoogle Scholar
  3. 3.
    Kato O, Kawasaki N, Bodri D et al (2012) Neonatal outcome and birth defects in 6623 singletons born following minimal ovarian stimulation and vitrified versus fresh single embryo transfer. Eur J Obstet Gynecol Reprod Biol 161:46–50CrossRefPubMedGoogle Scholar
  4. 4.
    Takahashi K, Mukaida T, Goto T et al (2005) Perinatal outcome of blastocyst transfer with vitrification using cryoloop: a 4-year follow-up study. Fertil Steril 84:88–92CrossRefPubMedGoogle Scholar
  5. 5.
    Gosden R (2011) Cryopreservation: a cold look at technology for fertility preservation. Fertil Steril 96:264–268CrossRefPubMedGoogle Scholar
  6. 6.
    Alpha Scientists in Reproductive Medicine (2012) The Alpha consensus meeting on cryopreservation key performance indicators and benchmarks: proceedings of an expert meeting. Reprod Biomed Online 25:146–167CrossRefGoogle Scholar
  7. 7.
    Kader AA, Choi A, Orief Y et al (2009) Factors affecting the outcome of human blastocyst vitrification. Reprod Biol Endocrinol 7:99CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Roy TK, Brandi S, Bradley CK et al (2016) Automatic vitrification: development of the Gavi system. In: Tucker MJ, Liebermann J (eds) Vitrification in Assisted Reproduction, 2nd edn. CRC Press, FloridaGoogle Scholar
  9. 9.
    Roy TK, Brandi S, Tappe NM et al (2014) Embryo vitrification using a novel semi-automated closed system yields in vitro outcomes equivalent to manual Cryotop method. Hum Reprod 29(11):2431–2438CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  • Tammie K. Roy
    • 1
    Email author
  • Susanna Brandi
    • 1
  • Teija T. Peura
    • 1
  1. 1.SydneyAustralia

Personalised recommendations